Hohaus S - Search Results

1

Whole blood EBV-DNA predicts outcome in diffuse large B-cell lymphoma.

Tisi MC, Cupelli E, Santangelo R, Maiolo E, Alma E, Giachelia M, Martini M, Bellesi S, D'Alò F, Voso MT, Pompili M, Leone G, Larocca LM, Hohaus S. Tisi MC, et al. Among authors: hohaus s. Leuk Lymphoma. 2016;57(3):628-34. doi: 10.3109/10428194.2015.1072766. Epub 2015 Oct 12. Leuk Lymphoma. 2016. PMID: 26458141

2

High-dose therapy with peripheral blood stem cell transplantation results in a significant reduction of the haemopoietic progenitor cell compartment.

Voso MT, Murea S, Goldschmidt H, Hohaus S, Haas R. Voso MT, et al. Among authors: hohaus s. Br J Haematol. 1996 Sep;94(4):759-66. doi: 10.1046/j.1365-2141.1996.02391.x. Br J Haematol. 1996. PMID: 8826907

3

Lack of t(14;18) polymerase chain reaction-positive cells in highly purified CD34+ cells and their CD19 subsets in patients with follicular lymphoma.

Voso MT, Hohaus S, Moos M, Haas R. Voso MT, et al. Among authors: hohaus s. Blood. 1997 May 15;89(10):3763-8. Blood. 1997. PMID: 9160682 Free article.

4

Telomerase activity in human hematopoietic progenitor cells.

Hohaus S, Voso MT, Orta-La Barbera E, Cavallo S, Bellacosa A, Rutella S, Rumi C, Genuardi M, Neri G, Leone G. Hohaus S, et al. Haematologica. 1997 May-Jun;82(3):262-8. Haematologica. 1997. PMID: 9234570

5

Mobilization and selection of CD34+ cells.

Hohaus S, Murea S, Voso MT, Haas R. Hohaus S, et al. Recent Results Cancer Res. 1998;144:1-7. Recent Results Cancer Res. 1998. PMID: 9304701 Review. No abstract available.

6

Efficacy and toxicity of sequential high-dose therapy with peripheral blood stem cell support in patients with high-risk breast cancer.

Hohaus S, Wallwiener D, Martin S, Voso MT, Huober J, Fersis N, Bastert G, Haas R. Hohaus S, et al. Semin Oncol. 1998 Apr;25(2 Suppl 4):7-11; discussion 45-8. Semin Oncol. 1998. PMID: 9578056 Clinical Trial.

7

Adjuvant high-dose therapy with peripheral blood stem cell support for patients with high-risk breast cancer.

Hohaus S, Martin S, Schneeweiss A, Voso MT, Schlenk RF, Wallwiener D, Bastert G, Haas R. Hohaus S, et al. Cancer Chemother Pharmacol. 1999;44 Suppl:S13-7. doi: 10.1007/s002800051110. Cancer Chemother Pharmacol. 1999. PMID: 10602904 Clinical Trial.

8

Prognostic factors for the clinical outcome of patients with follicular lymphoma following high-dose therapy and peripheral blood stem cell transplantation (PBSCT).

Voso MT, Martin S, Hohaus S, Abdallah A, Schlenk RF, Ho AD, Haas R. Voso MT, et al. Among authors: hohaus s. Bone Marrow Transplant. 2000 May;25(9):957-64. doi: 10.1038/sj.bmt.1702336. Bone Marrow Transplant. 2000. PMID: 10800063

9

In vivo depletion of B cells using a combination of high-dose cytosine arabinoside/mitoxantrone and rituximab for autografting in patients with non-Hodgkin's lymphoma.

Voso MT, Pantel G, Weis M, Schmidt P, Martin S, Moos M, Ho AD, Haas R, Hohaus S. Voso MT, et al. Among authors: hohaus s. Br J Haematol. 2000 Jun;109(4):729-35. doi: 10.1046/j.1365-2141.2000.02084.x. Br J Haematol. 2000. PMID: 10929022 Free article.

10

High-dose therapy with peripheral blood stem cell transplantation for patients with relapsed or refractory Hodgkin's disease: long-term outcome and prognostic factors.

Neben K, Hohaus S, Goldschmidt H, Egerer G, Voso MT, Ho AD, Haas R. Neben K, et al. Among authors: hohaus s. Ann Hematol. 2000 Oct;79(10):547-55. doi: 10.1007/s002770000190. Ann Hematol. 2000. PMID: 11100744

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

196 results

Search Page

Filters